{"nct_id":"NCT00932126","title":"This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors","status":"TERMINATED","status_verified_date":"2015-10","start_date":"2009-09","start_date_type":null,"primary_completion_date":"2011-12","primary_completion_date_type":"ACTUAL","completion_date":"2011-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["PFE"]}